Your browser doesn't support javascript.
loading
Defining and recognising locally advanced basal cell carcinoma.
Amici, Jean Michel; Battistella, Maxime; Beylot-Barry, Marie; Chatellier, Anne; Dalac-Ra, Sophie; Dreno, Brigitte; Falandry, Claire; Froget, Nicolas; Giacchero, Damien; Grob, Jean Jacques; Guerreschir, Pierre; Leccia, Marie-Thérèse; Malard, Olivier; Mortier, Laurent; Routier, Emilie; Stefan, Andreea; Stefan, Dinu; Stoebner, Pierre-Emmanuel; Basset-Seguin, Nicole.
Afiliação
  • Amici JM; Basal cell carcinoma French Expert Group.
  • Battistella M; Basal cell carcinoma French Expert Group.
  • Beylot-Barry M; Basal cell carcinoma French Expert Group.
  • Chatellier A; Basal cell carcinoma French Expert Group.
  • Dalac-Ra S; Basal cell carcinoma French Expert Group.
  • Dreno B; Basal cell carcinoma French Expert Group.
  • Falandry C; Basal cell carcinoma French Expert Group.
  • Froget N; Basal cell carcinoma French Expert Group.
  • Giacchero D; Basal cell carcinoma French Expert Group.
  • Grob JJ; Basal cell carcinoma French Expert Group.
  • Guerreschir P; Basal cell carcinoma French Expert Group.
  • Leccia MT; Basal cell carcinoma French Expert Group.
  • Malard O; Basal cell carcinoma French Expert Group.
  • Mortier L; Basal cell carcinoma French Expert Group.
  • Routier E; Basal cell carcinoma French Expert Group.
  • Stefan A; Basal cell carcinoma French Expert Group.
  • Stefan D; Basal cell carcinoma French Expert Group.
  • Stoebner PE; Basal cell carcinoma French Expert Group.
  • Basset-Seguin N; Basal cell carcinoma French Expert Group, Université Paris 7, hôpital Saint-Louis, 1 avenue Claude-Vellefaux, 75011 Paris.
Eur J Dermatol ; 25(6): 586-94, 2015.
Article em En | MEDLINE | ID: mdl-26574792
ABSTRACT

BACKGROUND:

Rarely, basal cell carcinomas (BCCs) have the potential to become extensively invasive and destructive, a phenomenon that has led to the term "locally advanced BCC" (laBCC). We identified and described the diverse settings that could be considered "locally advanced".

METHODS:

The panel of experts included oncodermatologists, dermatological and maxillofacial surgeons, pathologists, radiotherapists and geriatricians. During a 1-day workshop session, an interactive flow/sequence of questions and inputs was debated.

RESULTS:

Discussion of nine cases permitted us to approach consensus concerning what constitutes laBCC. The expert panel retained three major components for the complete assessment of laBCC cases factors of complexity related to the tumour itself, factors related to the operability and the technical procedure, and factors related to the patient. Competing risks of death should be precisely identified. To ensure homogeneous multidisciplinary team (MDT) decisions in different clinical settings, the panel aimed to develop a practical tool based on the three components.

CONCLUSION:

The grid presented is not a definitive tool, but rather, it is a method for analysing the complexity of laBCC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Sociedades Médicas / Carcinoma Basocelular / Guias de Prática Clínica como Assunto / Dermatologia Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Sociedades Médicas / Carcinoma Basocelular / Guias de Prática Clínica como Assunto / Dermatologia Idioma: En Ano de publicação: 2015 Tipo de documento: Article